ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 89 filers reported holding ALPINE IMMUNE SCIENCES INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.8%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Decheng Capital Management III (Cayman), LLC | 6,708,288 | $76,809,898 | 25.63% |
| Lynx1 Capital Management LP | 2,404,614 | $27,532,830 | 18.21% |
| GREAT POINT PARTNERS LLC | 3,078,633 | $35,250,348 | 6.42% |
| Ghost Tree Capital, LLC | 664,132 | $7,604,311 | 2.50% |
| Frazier Life Sciences Management, L.P. | 2,985,757 | $34,186,918 | 2.27% |
| Paradigm Biocapital Advisors LP | 2,421,743 | $27,728,957 | 1.88% |
| COMMODORE CAPITAL LP | 1,325,000 | $15,171,250 | 1.77% |
| Nan Fung Group Holdings Ltd | 182,280 | $2,087,106 | 1.69% |
| Omega Fund Management, LLC | 153,700 | $1,759,865 | 1.62% |
| Octagon Capital Advisors LP | 750,000 | $8,587,500 | 1.32% |
| Cormorant Asset Management, LP | 1,900,000 | $21,755,000 | 1.27% |
| Tri Locum Partners LP | 314,029 | $3,595,632 | 1.15% |
| Vivo Capital, LLC | 914,913 | $10,475,754 | 1.15% |
| RA Capital Management | 4,691,178 | $53,713,988 | 1.06% |
| Orbimed Advisors | 4,081,592 | $46,734,228 | 0.99% |
| Artal Group S.A. | 1,193,030 | $13,660 | 0.59% |
| SPHERA FUNDS MANAGEMENT LTD. | 180,000 | $2,061,000 | 0.38% |
| Avidity Partners Management LP | 657,280 | $7,525,856 | 0.30% |
| HighVista Strategies LLC | 39,861 | $456,408 | 0.21% |
| Woodline Partners LP | 1,038,777 | $11,893,997 | 0.14% |
External links
This page lists ALPINE IMMUNE SCIENCES INC's shareholders in Q3 2023. To view ALPINE IMMUNE SCIENCES INC's shareholder history, click here.